The
British Pharmacopeia (BP) and the United States Pharmacopeia (USP) formalized
their long-standing partnership to strengthen the quality of medicines and
improve public health around the world, in an agreement signed on Friday, July
26, at USP in Rockville, MD. Pharmacopoeial quality standards help drug manufacturers
and regulatory agencies ensure medicines quality.
The
formal Memorandum of Understanding establishes a framework for cooperative
activities, including developing drug product monographs, information sharing,
and expanding collaboration to new areas. The organizations intend to exchange
scientific staff and participate in joint events.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
No comments:
Post a comment
Pharmaceutical Microbiology Resources